AUGELLO, Giuseppa
 Distribuzione geografica
Continente #
NA - Nord America 1.252
EU - Europa 528
AS - Asia 198
AF - Africa 11
OC - Oceania 1
SA - Sud America 1
Totale 1.991
Nazione #
US - Stati Uniti d'America 1.252
IT - Italia 270
CN - Cina 114
SG - Singapore 64
FI - Finlandia 47
IE - Irlanda 43
DE - Germania 37
UA - Ucraina 30
SE - Svezia 28
GB - Regno Unito 18
BE - Belgio 13
RU - Federazione Russa 13
FR - Francia 10
IN - India 9
CI - Costa d'Avorio 7
HK - Hong Kong 6
RO - Romania 5
EG - Egitto 4
CZ - Repubblica Ceca 3
ES - Italia 3
IR - Iran 3
CH - Svizzera 2
GR - Grecia 2
PL - Polonia 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
NL - Olanda 1
NO - Norvegia 1
PK - Pakistan 1
VE - Venezuela 1
Totale 1.991
Città #
Fairfield 168
Chandler 151
Woodbridge 99
Ashburn 87
Ann Arbor 76
Seattle 68
Houston 63
Cambridge 62
Wilmington 62
Des Moines 60
Palermo 52
Singapore 51
Dublin 43
Medford 35
New York 30
Nanjing 23
Princeton 20
Altamura 16
Jacksonville 16
Brussels 13
San Diego 12
Shenyang 12
Lawrence 11
Nanchang 11
Bremen 10
Milan 10
Rome 9
Changsha 8
Falls Church 8
Abidjan 7
Beijing 7
Jinan 7
Tulsa 7
Turin 7
Foggia 6
Hangzhou 6
Hebei 6
Naples 6
Ningbo 6
Hong Kong 5
Jiaxing 5
Lanzhou 5
Ludwigshafen am Rhein 5
Napoli 5
Boardman 4
Dearborn 4
Haikou 4
Kolkata 4
Moscow 4
Norwalk 4
Tianjin 4
Washington 4
Brno 3
Catanzaro 3
Dallas 3
Florence 3
Kilburn 3
London 3
Santa Clara 3
Siano 3
Trapani 3
Venice 3
Abbey Wood 2
Alessandria 2
Angri 2
Ardabil 2
Bologna 2
Bordeaux 2
Borgomanero 2
Burgos 2
Caserta 2
Cefalù 2
Como 2
Guangzhou 2
Helsinki 2
Lamezia Terme 2
Leverano 2
Minya 2
Mirabello Sannitico 2
Motta Sant'Anastasia 2
Orange 2
Padova 2
Phoenix 2
Redwood City 2
Rimini 2
San Giovanni Teatino 2
Weimar 2
Alcamo 1
Athens 1
Bedford 1
Benevento 1
Bergamo 1
Brescia 1
Busto Arsizio 1
Cagliari 1
Cantu 1
Castelletto sopra Ticino 1
Catania 1
Catford 1
Centrale 1
Totale 1.501
Nome #
Electrophoretic Mobility Shift Assay (EMSA) or Gel Shift Assay 184
NUPR1, a new target in liver cancer: implication in controlling cell growth, migration, invasion and sorafenib resistance 184
In human retinoblastoma Y79 cells okadaic acid–parthenolide co-treatment induces synergistic apoptotic effects, with PTEN as a key player. 158
Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma 151
Cytokine profile of breast cell lines after different radiation doses 126
Oleocanthal exerts antitumor effects on human liver and colon cancer cells through ROS generation 120
Pivotal roles of glycogen synthase-3 in hepatocellular carcinoma 118
A PTEN inhibitor displays preclinical activity against hepatocarcinoma cells 115
Association between MICA Gene Variants and the Risk of Hepatitis C Virus-Induced Hepatocellular Cancer in a Sicilian Population Sample 106
Cationic Solid Lipid Nanoparticles (SLN) for shNupr1 plasmid delivery in the treatment of hepatocellular carcinoma (HCC) 97
Two single nucleotide polymorphisms in the MICA gene and sMICA plasma levels are associated with hepatocellular carcinoma development in an Italian population of HCV related liver cirrhosis 83
Delivery of shRNA plasmid DNA by cationic solid lipid nanoparticles for gene silencing in human hepatocarcinoma cells 79
Western Blotting Analysis 78
PROLONGED TREATMENT OF HUMAN OSTEOSARCOMA MG63 CELLS WITH 3AB INDUCES THE PRODUCTION OF TUMOR INITIATING CELLS. 75
Cationic solid lipid nanoparticles complexed with genetic material for liver tumor treatment 74
Delivery of shNupr1 plasmid by solid lipid nanoparticles reduces the expression of Nupr1 gene in hepatocellular carcinoma cells 74
In Human Retinoblastoma Y-79 Cells 3-aminobenzamide induces Differentiation 64
miR-126-3p and miR-21-5p as Hallmarks of Bio-Positive Ageing; Correlation Analysis and Machine Learning Prediction in Young to Ultra-Centenarian Sicilian Population. 63
NUPR1 protects liver from lipotoxic injury by improving the endoplasmic reticulum stress response 49
The NUPR1/p73 axis contributes to sorafenib resistance in hepatocellular carcinoma 49
Outcome predictors in SARS-CoV-2 disease (COVID-19): The prominent role of IL-6 levels and an IL-6 gene polymorphism in a western Sicilian population 35
Genetic biomarkers for sorafenib response in patients with hepatocellular carcinoma 20
Totale 2.102
Categoria #
all - tutte 8.116
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.116


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020242 0 0 0 0 0 52 39 28 35 26 56 6
2020/2021206 15 8 6 20 11 2 29 19 11 21 38 26
2021/2022304 6 59 17 24 9 12 12 19 25 33 27 61
2022/2023478 34 56 24 55 32 78 65 47 51 9 16 11
2023/2024203 10 24 20 14 15 46 21 15 9 10 2 17
2024/2025113 12 24 20 27 25 5 0 0 0 0 0 0
Totale 2.102